| CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials KF Schulz, DG Altman, D Moher Journal of Pharmacology and pharmacotherapeutics 1 (2), 100-107, 2010 | 22450 | 2010 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group International journal of surgery 8 (5), 336-341, 2010 | 22121* | 2010 |
| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 5999 | 2013 |
| The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations B Hutton, G Salanti, DM Caldwell, A Chaimani, CH Schmid, C Cameron, ... Annals of internal medicine 162 (11), 777-784, 2015 | 5626 | 2015 |
| SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ... Bmj 346, 2013 | 4961 | 2013 |
| Publication bias in meta‐analysis HR Rothstein, AJ Sutton, M Borenstein Publication bias in meta‐analysis: Prevention, assessment and adjustments, 1-7, 2005 | 3244 | 2005 |
| Systematic reviews: identifying relevant studies for systematic reviews K Dickersin, R Scherer, C Lefebvre Bmj 309 (6964), 1286-1291, 1994 | 2379 | 1994 |
| The prevention and treatment of missing data in clinical trials RJ Little, R D'agostino, ML Cohen, K Dickersin, SS Emerson, JT Farrar, ... New England Journal of Medicine 367 (14), 1355-1360, 2012 | 2160* | 2012 |
| The existence of publication bias and risk factors for its occurrence K Dickersin Jama 263 (10), 1385-1389, 1990 | 1755 | 1990 |
| Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards K Dickersin, YI Min, CL Meinert Jama 267 (3), 374-378, 1992 | 1077 | 1992 |
| Publication bias in clinical trials due to statistical significance or direction of trial results S Hopewell, K Loudon, MJ Clarke, AD Oxman, K Dickersin Cochrane Database of Systematic Reviews, 2009 | 1060 | 2009 |
| Contaminated water supplies at Camp Lejeune: Assessing potential health effects National Research Council, Division on Earth, Life Studies, ... National Academies Press, 2009 | 960* | 2009 |
| Increasing value and reducing waste: addressing inaccessible research AW Chan, F Song, A Vickers, T Jefferson, K Dickersin, PC Gøtzsche, ... The Lancet 383 (9913), 257-266, 2014 | 913 | 2014 |
| Publication bias and clinical trials K Dickersin, SS Chan, TC Chalmersx, HS Sacks, H Smith Jr Controlled clinical trials 8 (4), 343-353, 1987 | 865 | 1987 |
| Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed KA Robinson, K Dickersin International journal of epidemiology 31 (1), 150-153, 2002 | 862 | 2002 |
| CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration S Hopewell, M Clarke, D Moher, E Wager, P Middleton, DG Altman, ... PLoS medicine 5 (1), e20, 2008 | 750 | 2008 |
| Meta-analysis: state-of-the-science K Dickersin, JA Berlin Epidemiologic reviews 14 (1), 154-176, 1992 | 670 | 1992 |
| Osteoporosis prevention, diagnosis, and therapy A Klibanski, L Adams-Campbell, T Bassford, SN Blair, SD Boden, ... Journal of the American medical association 285 (6), 785-795, 2001 | 582 | 2001 |
| Registering clinical trials K Dickersin, D Rennie Jama 290 (4), 516-523, 2003 | 572 | 2003 |
| Getting to grips with Archie Cochrane's agenda. I Chalmers, K Dickersin, TC Chalmers BMJ: British Medical Journal 305 (6857), 786, 1992 | 540 | 1992 |
Jesse A BerlinVP, Epidemiology, Janssen Research and Development在 its.jnj.com 的电子邮件经过验证
